Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 302

Showing 1-25 of 302 citing articles:

Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 83
Advances in Glioblastoma Therapy: An Update on Current Approaches
Ramcharan Singh Angom, Naga Malleswara Rao Nakka, Santanu Bhattacharya
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 74
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 58
Immunotherapy in glioblastoma treatment: Current state and future prospects
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 4, pp. 138-159
Open Access | Times Cited: 51
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 42
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Su Hyun Lim, Gi Taek Yee, Dongwoo Khang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2529-2552
Open Access | Times Cited: 16
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
Dávid Sipos, Bence L. Raposa, Omar Freihat, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 146-146
Open Access | Times Cited: 2
Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma
Angie Bates, Kameron L. Klugh, Anna O. Galaeva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 994-994
Open Access | Times Cited: 2
New Directions in the Therapy of Glioblastoma
Katarzyna Szklener, Marek Mazurek, Małgorzata Wieteska, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5377-5377
Open Access | Times Cited: 59
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
Uğur Sener, Michael W. Ruff, Jian L. Campian
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7046-7046
Open Access | Times Cited: 45
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
Beatrice Dufrusine, Emily Capone, Sara Ponziani, et al.
Molecular Oncology (2023) Vol. 17, Iss. 8, pp. 1460-1473
Open Access | Times Cited: 23
Enhancing Photothermal/Photodynamic Therapy for Glioblastoma by Tumor Hypoxia Alleviation and Heat Shock Protein Inhibition Using IR820-Conjugated Reduced Graphene Oxide Quantum Dots
Banendu Sunder Dash, Yu‐Jen Lu, Jyh‐Ping Chen
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 11, pp. 13543-13562
Closed Access | Times Cited: 14
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
Cannabidiol induces ERK activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells
Na Young Kim, Siddegowda Gopalapura Shivanne Gowda, Seok‐Geun Lee, et al.
Chemico-Biological Interactions (2024) Vol. 394, pp. 110995-110995
Closed Access | Times Cited: 13
Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions
Abdulhameed Al‐Ghabkari, Bruce Huang, Morag Park
Cells (2024) Vol. 13, Iss. 3, pp. 218-218
Open Access | Times Cited: 10
The Role of Transglutaminase 2 in Cancer: An Update
Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2797-2797
Open Access | Times Cited: 10
TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO
Yike Chen, Xiaohui Xu, Kaikai Ding, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
Micropeptide AF127577.4-ORF hidden in a lncRNA diminishes glioblastoma cell proliferation via the modulation of ERK2/METTL3 interaction
Baoshun Du, Zheying Zhang, Linlin Jia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Emerging Therapies for Glioblastoma
Stella Rios, Stephanie Oyervides, David Uribe, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1485-1485
Open Access | Times Cited: 8
Viruses in glioblastoma: an update on evidence and clinical trials
Bavani Gunasegaran, Caroline L. Ashley, Felix Marsh‐Wakefield, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles
Jain Koo, Yuseon Shin, Hyewon Jeon, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 997-1012
Closed Access | Times Cited: 1
Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Small (2025)
Closed Access | Times Cited: 1
Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (Potamotrygon spp.) as a Drug Carrier in Glioblastoma Cancer Cells
Alejandro Manzanares-Guzmán, Andrea P. Guevara, Elia Reza-Escobar, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 876-876
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top